Science and Technology Assisting Third Thesis

Excerpt from Thesis :

I would also argue that these donations were not expenses; they are investments in these economies and their growth. It is in furthering the standard of living for these nations that the corporation I was leader of fulfilled its mission as an organization. In any organization capable of this level of philanthropy there is also the ability to invest in new product development. Concentrating on partnering with these nations and with other companies is critical for the long-term viability of their economies and for the growth of CSR programs globally in the pharmaceutical industry (Wechsler, 2006). While there is not an ethical requirement to do this, there is the moralistic one and more importantly, the need to do well by doing good and enriching others less fortunate.


Craig Smith. (2009). Bounded goodness: marketing implications of Drucker on corporate responsibility. Academy of Marketing Science. Journal, 37(1), 73.

Retrieved March 6, 2009, from ABI/INFORM Global database. (Document ID: 1654388551).

Jill Wechsler. (2006, September). New Partnerships Pursue Old Diseases. Pharmaceutical Executive, 26(9),…
IMPORTANT:  We are only showing you a small preview of the full completed paper. The file you download will contain the full (1)-pages and be correctly formatted.

Cite This Thesis:

"Science And Technology Assisting Third" (2009, March 09) Retrieved September 24, 2017, from

"Science And Technology Assisting Third" 09 March 2009. Web.24 September. 2017. <>

"Science And Technology Assisting Third", 09 March 2009, Accessed.24 September. 2017,